Compare FLL & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLL | ASRT |
|---|---|---|
| Founded | 1987 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.7M | 76.0M |
| IPO Year | 2014 | 2004 |
| Metric | FLL | ASRT |
|---|---|---|
| Price | $2.62 | $11.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $4.00 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 131.0K | 24.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 95.07 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $292,065,000.00 | $124,961,000.00 |
| Revenue This Year | $8.87 | N/A |
| Revenue Next Year | $5.50 | $1.42 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 21.16 | N/A |
| 52 Week Low | $2.02 | $0.51 |
| 52 Week High | $4.95 | $12.95 |
| Indicator | FLL | ASRT |
|---|---|---|
| Relative Strength Index (RSI) | 58.25 | 50.67 |
| Support Level | $2.55 | $11.05 |
| Resistance Level | $2.99 | $12.45 |
| Average True Range (ATR) | 0.20 | 0.46 |
| MACD | 0.06 | -0.15 |
| Stochastic Oscillator | 68.75 | 38.46 |
Full House Resorts Inc owns, operates, develops, manages, and invests in casinos and related hospitality and entertainment facilities. It offers facilities related to gaming, hotel, dining, entertainment, retail, and other amenities. The group's reportable segments are Midwest & South, West, and Contracted Sports Wagering, It generates the majority of its revenue from the Midwest & South segment which includes Silver Slipper Casino and Hotel, Rising Star Casino Resort, and American Place. The west segment includes Grand Lodge, Stockman's Casino, Bronco Billy's Casino and Hotel, and Chamonix Casino Hotel. The Contracted Sports Wagering segment comprises on-site and online sports wagering skins.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.